NEURO62

Session information

English Poster Session

[Pe-09] English Poster Session 09 Neuroimmunology 02

Wed. May 19, 2021 6:15 PM - 6:55 PM Room 15 (ICC Kyoto 1F New Hall)

Akihiro Nakajima1, Etsuji Saji1, Hiroshi Shimizu3, Takahiro Wakasugi1, Fumihiro Yanagimura4, Kaori Yanagawa1, Masatoyo Nishizawa5, Akiyoshi Kakita3, Osamu Onodera1, Izumi Kawachi1,2 (1.Department of Neurology, Brain Research Institute, Niigata University, Japan, 2.Comprehensive Medical Education Center, Niigata University School of Medicine, Niigata, Japan, 3.Department of Pathology, Brain Research Institute, Niigata University, 4.Nagaoka Chuo General Hospital, 5.4)Niigata University of Health and Welfare, Niigata, Japan)

Mamoru Yamamoto1, Tathusada Okuno2, Jin-lan Piao1, Mikito Shimizu2, Takamasa Nukui1, Tohru Kouda2, Katsuichi Miyamoto3, Makoto Kinoshita2, Tomohiro Hayashi3, Hirohumi Konishi1, Nobuhiro Dougu1, Ratna Dini Haryun1, Yuji Nakatuji1 (1.Department of Neurology, Faculty of Medicine, University of Toyama, Japan, 2.Department of Neurology, Osaka University Graduate School of Medicine, 3.Department of Neurology, Kindai University Hospital)

Etsuji Saji1, Akihiro Nakajima1, Takahiro Wakasugi1, Fumihiro Yanagimura2, Kaori Yanagawa1, Masatoyo Nishizawa3, Osamu Onodera1, Izumi Kawachi1,4 (1.Department of Neurology, Brain Research Institute, Niigata University, Japan, 2.Department of Neurology, Nagaoka Chuo General Hospital, 3.Niigata University of Health and Welfare, 4.Comprehensive Medical Education Center, Niigata University School of Medicine)

Takashi Yamamura1, Manabu Araki1, Tatsusada Okuno2, Tatsuro Misu3, Yuh-cherng Guo4, Cheryl Hemingway5, Junnosuke Matsushima6, Naofumi Sugaya6, Masami Yamashita6, H.-christian Von Büdingen7, Katsuichi Miyamoto8 (1.National Center Hospital of Neurology and Psychiatry, Tokyo, Japan, 2.Division of Neurology, Osaka University, Osaka, Japan, 3.Department of Neurology, Tohoku University, Sendai, Japan·, 4.China Medical University Hospital, Taiwan, 5.Great Ormond Street Hospital for Children, UK, 6.Chugai Pharmaceutical Co. Ltd, Tokyo, Japan, 7.F. Hoffmann-La Roche Ltd, Basel, Switzerland, 8.Department of Medicine, Graduate School of Medical Sciences, Kindai University, Osaka, Japan)

Kazuo Fujihara1,2, Michael Levy3, Achim Berthele4, Ho Jin Kim5, Ichiro Nakashima6, Celia Oreja-guevara7, Jacqueline Palace8, Sean J Pittock9, Murat Terzi10, Dean M Wingerchuk9 (1.Southern TOHOKU Research Institute for Neuroscience (STRINS), Japan, 2.Fukushima Medical University, Japan, 3.Massachusetts General Hospital and Harvard Medical School, 4.Technical University of Munich, 5.Research Institute and Hospital, Goyang, 6.Tohoku Medical and Pharmaceutical University, 7.Hospital Universitario Clinico San Carlos, 8.John Radcliffe Hospita, 9.Mayo Clinic, 10.Ondokuz Mayis University)

Takahiro Wakasugi1, Etsuji Saji1, Akihiro Nakajima1, Fumihiro Yanagimura3, Kaori Yanagawa1, Masatoyo Nishizwa4, Osamu Onodera1, Izumi Kawachi1,2 (1.Department of Neurology, Brain Research Institute, Niigata University, Japan, 2.Comprehensive Medical Education Center, Niigata University School of Medicine, 3.Department of Neurology, Nagaoka Chuo General Hospital, 4.Niigata University of Health and Welfare)